Literature DB >> 10475888

Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study.

A G Bostom1, I H Rosenberg, H Silbershatz, P F Jacques, J Selhub, R B D'Agostino, P W Wilson, P A Wolf.   

Abstract

BACKGROUND: Total homocysteine levels are associated with arteriosclerotic outcomes.
OBJECTIVE: To determine whether total homocysteine levels predict incident stroke in elderly persons.
DESIGN: Prospective population-based cohort study with 9.9 years of follow-up.
SETTING: Framingham, Massachusetts. PATIENTS: 1947 Framingham Study participants (1158 women and 789 men; mean age +/- SD, 70 +/- 7 years). MEASUREMENTS: Baseline total homocysteine levels and 9.9-year stroke incidence.
RESULTS: The quartiles of nonfasting total homocysteine levels were as follows: quartile 1, 4.13 to 9.25 micromol/L; quartile 2, 9.26 to 11.43 micromol/L; quartile 3, 11.44 to 14.23 micromol/L; quartile 4, 14.24 to 219.84 micromol/L. During follow-up, 165 incident strokes occurred. In proportional hazards models adjusted for age, sex, systolic blood pressure, diabetes, smoking, and history of atrial fibrillation and coronary heart disease, relative risk (RR) estimates comparing quartile 1 with the other three quartiles were as follows: quartile 2 compared with quartile 1--RR, 1.32 (95% CI, 0.81 to 2.14); quartile 3 compared with quartile 1--RR, 1.44 (CI, 0.89 to 2.34); quartile 4 compared with quartile 1--RR, 1.82 (CI, 1.14 to 2.91). The linear trend across the quartiles was significant (P < 0.001).
CONCLUSION: Nonfasting total homocysteine levels are an independent risk factor for incident stroke in elderly persons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475888     DOI: 10.7326/0003-4819-131-5-199909070-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  74 in total

Review 1.  Blood levels of homocysteine and atherosclerotic vascular disease.

Authors:  W G Christen; P M Ridker
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Secondary prevention for stroke and transient ischaemic attacks: Horizons needs expanding.

Authors:  Sumantra Ray; Alexander S F Doney; Ronald S MacWalter
Journal:  BMJ       Date:  2004-04-10

Review 3.  Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).

Authors:  Zoltán Szolnoki
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 4.  An update on treatment and prevention strategies for Alzheimer's disease.

Authors:  Judith Neugroschl; Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

5.  Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease.

Authors:  Shengfang Chen; Ping Wu; Lin Zhou; Yuqin Shen; Yunjie Li; Haoming Song
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 6.  [Thrombophilias in patients with ischemic stroke. Indication and calculated costs for evidence-based diagnostics and treatment].

Authors:  R Weber; E Busch
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

7.  Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study.

Authors:  Kirk I Erickson; Barbara L Suever; Ruchika Shaurya Prakash; Stanley J Colcombe; Edward McAuley; Arthur F Kramer
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

8.  Resolution of cor pulmonale after medical management in a patient with cblC-type methylmalonic aciduria and homocystinuria: a case report.

Authors:  Laurie Profitlich; Brian Kirmse; Melissa P Wasserstein; George Diaz; Shubhika Srivastava
Journal:  Cases J       Date:  2009-07-30

9.  Associations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controls.

Authors:  G Vyssoulis; E Karpanou; S-M Kyvelou; D Adamopoulos; T Gialernios; E Gymnopoulou; D Cokkinos; C Stefanadis
Journal:  J Hum Hypertens       Date:  2009-06-11       Impact factor: 3.012

10.  Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's Disease.

Authors:  Sung Rae Kim; Seong Hye Choi; Choong Kun Ha; Shin Goo Park; Hae Wook Pyun; Dae Hyun Yoon
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.